New Study Shows Cannabis Users NOT Lazy
Adult and adolescent cannabis users are no more likely than non-users to lack motivation or be unable to enjoy life’s pleasure, new research has shown, suggesting there is no scientific basis for the stereotype often portrayed in the media.
We’re so used to seeing ‘lazy stoners’ on our screens that we don’t stop to ask whether they’re an accurate representation of cannabis users. Our work implies that this is in itself a lazy stereotype
Cannabis users also show no difference in motivation for rewards, pleasure taken from rewards, or the brain’s response when seeking rewards, compared to non-users.
Cannabis is the third most commonly used controlled substance worldwide, after alcohol and nicotine. A 2018 report from the NHS Digital Lifestyles Team stated that almost one in five (19%) of 15-year-olds in England had used cannabis in the previous 12 months, while in 2020 the National Institute on Drug Abuse reported the proportion in the United States to be 28% of 15-16-year-olds.
A common stereotype of cannabis users is the ‘stoner’ – think Jesse Pinkman in Breaking Bad, The Dude in The Big Lebowski, or, more recently, Argyle in Stranger Things. These are individuals who are generally depicted as lazy and apathetic.
At the same time, there has been considerable concern of the potential impact of cannabis use on the developing brain and that using cannabis during adolescence might have a damaging effect at an important time in an individual’s life.
A team led by scientists at UCL, the University of Cambridge and the Institute of Psychiatry, Psychology & Neuroscience at King’s College London carried out a study examining whether cannabis users show higher levels of apathy (loss of motivation) and anhedonia (loss of interest in or pleasure from rewards) when compared to controls and whether they were less willing to exert physical effort to receive a reward. The research was part of the CannTEEN study.
The results are published in the International Journal of Neuropsychopharmacology.
The team recruited 274 adolescent and adult cannabis users who had used cannabis at least weekly over the past three months, with an average of four days per week, and matched them with non-users of the same age and gender.
Participants completed questionnaires to measure anhedonia, asking them to rate statements such as “I would enjoy being with family or close friends”. They also completed questionnaires to measure their levels of apathy, which asked them to rate characteristics such as how interested they were in learning new things or how likely they were to see a job through to the end.
Cannabis users scored slightly lower than non-users on anhedonia – in other words, they appeared better able to enjoy themselves – but there was no significant difference when it came to apathy. The researchers also found no link between frequency of cannabis use and either apathy or anhedonia in the people who used cannabis.
Martine Skumlien, a PhD candidate in the Department of Psychiatry at the University of Cambridge, said: “We were surprised to see that there was really very little difference between cannabis users and non-users when it came to lack of motivation or lack of enjoyment, even among those who used cannabis every day. This is contrary to the stereotypical portrayal we see on TV and in movies.”
In general, adolescents tended to score higher than adults on anhedonia and apathy in both user and non-user groups, but cannabis use did not augment this difference.
Dr Will Lawn, from the Institute of Psychiatry, Psychology and Neuroscience at King’s College London, said: “There’s been a lot of concern that cannabis use in adolescence might lead to worse outcomes than cannabis use during adulthood. But our study, one of the first to directly compare adolescents and adults who use cannabis, suggests that adolescents are no more vulnerable than adults to the harmful effects of cannabis on motivation, the experience of pleasure, or the brain’s response to reward.
“In fact, it seems cannabis may have no link – or at most only weak associations – with these outcomes in general. However, we need studies that look for these associations over a long period of time to confirm these findings.”
Just over half of participants also carried out a number of behavioural tasks. The first of these assessed physical effort. Participants were given the option to perform button-presses in order to win points, which were later exchanged for chocolates or sweets to take home. There were three difficulty levels and three reward levels; more difficult trials required faster button pressing. On each trial the participant could choose to accept or reject the offer; points were only accrued if the trial was accepted and completed.
In a second task, measuring how much pleasure they received from rewards, participants were first told to estimate how much they wanted to receive each of three rewards (30 seconds of one of their favourite songs, one piece of chocolate or a sweet, and a £1 coin) on a scale from ‘do not want at all’ to ‘intensely want’. They then received each reward in turn and were asked to rate how pleasurable they found them on a scale from ‘do not like at all’ to ‘intensely like’.
The researchers found no difference between users and non-users or between age groups on either the physical effort task or the real reward pleasure task, confirming evidence from other studies that found no, or very little, difference.
Skumlien added: “We’re so used to seeing ‘lazy stoners’ on our screens that we don’t stop to ask whether they’re an accurate representation of cannabis users. Our work implies that this is in itself a lazy stereotype, and that people who use cannabis are no more likely to lack motivation or be lazier than people who don’t.
“Unfair assumptions can be stigmatising and could get in the way of messages around harm reduction. We need to be honest and frank about what are and are not the harmful consequences of drug use.”
Earlier this year, the team published a study that used functional magnetic resonance imaging (fMRI) to look at brain activity in the same participants as they took part in a brain imaging task measuring reward processing. The task involved participants viewing orange or blue squares while in the scanner. The orange squares would lead to a monetary reward, after a delay, if the participant made a response.
The researchers used this set up to investigate how the brain responds to rewards, focusing in particular on the ventral striatum, a key region in the brain’s reward system. They found no relationship between activity in this region and cannabis use, suggesting that cannabis users had similar reward systems as non-users.
Professor Barbara Sahakian, from the Department of Psychiatry at the University of Cambridge, said: “Our evidence indicates that cannabis use does not appear to have an effect on motivation for recreational users. The participants in our study included users who took cannabis daily and they were no more likely to lack motivation. However, we cannot rule out the possibility that greater use, as seen in some people with cannabis-use disorder, has an effect.
“Until we have future research studies that follow adolescent users, starting from onset through to young adulthood, and which combine measures of motivation and brain imaging, we cannot determine for certain that regular cannabis use won’t negatively impact motivation and the developing brain.”
This research was funded by the Medical Research Council with additional support from the Aker Foundation, National Institute for Health Research and Wellcome.
Skumlien, M, et al. Anhedonia, apathy, pleasure, and effort-based decision-making in adult and adolescent cannabis users and controls. IJNP; 24 Aug 2022; DOI: 10.1093/ijnp/pyac056
Selamoglu, A, Langley, C et al. Neuropsychological performance in young adults with cannabis use disorder. Journal of Psychopharmacology; 25 Oct 2021; DOI: 10.1177/02698811211050548
New Study Shows Cannabis Users NOT Lazy
About Cannin: Your Cannabis Stocks Resource
78% of Cannin’s fundamentals prove true within 30 days or less on 100+ recommendations over the past 2 years.
Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. In fact, we aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2021.
Use Cannin as your resource for:
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Are you looking to buy stock in hemp companies or marijuana companies for 2021? If so, are you interested in new penny hemp stock companies? Or, looking for the best Canadian cannabis stocks to invest in? Maybe, you’re looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.
Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.
- +34% Gains in 2022
- +56% Gains in 2021
- +30% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
In fact, we’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one week risk-free trial to see it for yourself.
Profit from the best cannabis stocks – we’ll show you how at cannin.com.